Feedback / Questions
loxicodegol (NKTR-181) - Nektar Therapeutics
Nektar Therapeutics: J.P.Morgan Healthcare Conference
(Nektar Therapeutics)
-
Jan 17, 2016 -
Anticipated initiation of P3 efficacy SUMMIT-12 trial in chronic low back pain in H2 2016
Anticipated new P3 trial
•
Pain
http://www.nektar.com/pdf/2016_JPM-NKTR-FINAL.pdf
Jan 17, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.